BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25970161)

  • 1. VEGF and its receptors in dengue virus infection.
    Kalita J; Chauhan PS; Mani VE; Bhoi SK; Misra UK
    J Med Virol; 2015 Sep; 87(9):1449-55. PubMed ID: 25970161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever.
    Srikiatkhachorn A; Ajariyakhajorn C; Endy TP; Kalayanarooj S; Libraty DH; Green S; Ennis FA; Rothman AL
    J Virol; 2007 Feb; 81(4):1592-600. PubMed ID: 17151115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is VEGF a marker of severity of scrub typhus infection?
    Mani VE; Chauhan PS; Kalita J; Bhoi SK; Misra UK
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):305-10. PubMed ID: 26718940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
    Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
    Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Berezowska A; Radziszewski J; Bidzinski M; Kowalska M
    PLoS One; 2017; 12(10):e0184576. PubMed ID: 28991928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding complications in dengue are not associated with significant changes in the modulators of the endothelial barrier.
    Orsi FA; Angerami RN; Mazetto BM; Quaino SK; De Paula EV; Annichino-Bizzachi JM
    J Infect Dev Ctries; 2014 Jun; 8(6):799-803. PubMed ID: 24916883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vascular endothelial growth factor (VEGF) in the neurological manifestations of dengue: a preliminary study.
    Misra UK; Kalita J; Singh AP
    Inflammation; 2014 Apr; 37(2):611-4. PubMed ID: 24292799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
    Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
    Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D; Szabo L; Sator M; Just A; Egarter C
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism.
    Emanuele E; Orsi P; Barale F; di Nemi SU; Bertona M; Politi P
    Clin Biochem; 2010 Feb; 43(3):317-9. PubMed ID: 19850021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue.
    Bobic S; Hox V; Callebaut I; Vinckier S; Jonckx B; Stassen JM; Jorissen M; Gevaert P; Carmeliet P; Bachert C; Ceuppens JL; Hellings PW
    Allergy; 2014 Feb; 69(2):237-45. PubMed ID: 24127643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
    Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
    Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
    Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
    Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome].
    Kalitin NN; Dudina GA; Semochkin SV; Karamysheva AF
    Ter Arkh; 2017; 89(7):39-44. PubMed ID: 28766539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.